India Multiomics Market Size & Outlook, 2026-2033
Global Market
Related Markets
India multiomics market highlights
- The India multiomics market generated a revenue of USD 79.8 million in 2025 and is expected to reach USD 346.3 million by 2033.
- The India market is expected to grow at a CAGR of 20.1% from 2026 to 2033.
- In terms of segment, bulk multiomics was the largest revenue generating type in 2025.
- Single-cell Multiomics is the most lucrative type segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2025 | USD 79.8 million |
| Market revenue in 2033 | USD 346.3 million |
| Growth rate | 20.1% (CAGR from 2026 to 2033) |
| Largest segment | Bulk multiomics |
| Fastest growing segment | Single-cell Multiomics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single-cell Multiomics, Bulk Multiomics |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, India accounted for 2.5% of the global multiomics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China multiomics market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 346.3 million by 2033.
Over the past few decades, India has become a hub for pharmaceutical and biotechnology companies and has gained global attention due to the presence of skilled & knowledgeable manpower and low capital investments.
With its abundant resources and a substantial number of established research & development institutions, India has emerged as a pivotal location for multinational corporations to establish research laboratories and manufacturing facilities.
Furthermore, government initiatives play a vital role in expanding the overall market growth. For instance, the Indian Cancer Genome Atlas (ICGA) was launched in 2020 by the Indian government to promote R&D in multiomics.
No credit card required*
Publish Date: Jun 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Shimadzu Corp | View profile | 15,284 | 1, Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto, Japan, 604-8511 | www.shimadzu.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Revvity Inc | View profile | 11,500 | 940 Winter Street, Waltham, MA, United States, 02451 | www.revvity.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | www.genomics.cn/ |
India Multiomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multiomics Market Outlook will help companies and investors design strategic landscapes.
Bulk Multiomics was the largest segment with a revenue share of 79.57% in 2025.
Horizon Databook has segmented the India multiomics market based on single-cell multiomics, bulk multiomics covering the revenue growth of each sub-segment from 2021 to 2033.
Over the past few decades, India has become a hub for pharmaceutical and biotechnology companies and has gained global attention due to the presence of skilled & knowledgeable manpower and low capital investments.
With its abundant resources and a substantial number of established research & development institutions, India has emerged as a pivotal location for multinational corporations to establish research laboratories and manufacturing facilities.
Furthermore, government initiatives play a vital role in expanding the overall market growth. For instance, the Indian Cancer Genome Atlas (ICGA) was launched in 2020 by the Indian government to promote R&D in multiomics.
- India Multiomics Market Type Outlook (Revenue, USD Million , 2021-2033)
- Single-cell Multiomics
- Bulk Multiomics
- India Multiomics Market Platform Outlook (Revenue, USD Million , 2021-2033)
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Integrated Omics Platforms
- India Multiomics Market Product & Service Outlook (Revenue, USD Million , 2021-2033)
- Services
- Product
- India Multiomics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Others
- Academic & Research Institutes
- India Multiomics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Immunology
- Cell Biology
- Oncology
- Neurology
Reasons to subscribe to Multiomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multiomics Market Outlook databook
- Our clientele includes a mix of Multiomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Multiomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Multiomics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Multiomics Market, 2021-2033 (US$M)
India Type - Multiomics Market Statistics, 2025 - 2033 (US$M)
